false
Catalog
Maniilaq ORN Training: Prescribing Buprenorphine f ...
Prescribing Buprenorphine for Chronic Pain Slides
Prescribing Buprenorphine for Chronic Pain Slides
Back to course
Pdf Summary
The document discusses the use of buprenorphine for chronic pain management, particularly in patients already dependent on full opioid agonists. It emphasizes harm reduction and off-label use of buprenorphine as an alternative to traditional opioids for chronic pain. Various guidelines recommend transitioning high-risk patients to buprenorphine due to its lower overdose and misuse risks. The text highlights the benefits of buprenorphine in reducing opioid-related risks, improving quality of life for chronic pain patients, and minimizing respiratory depression, even in opioid-naïve individuals.<br /><br />Furthermore, the document outlines dosing options, initiation strategies, and formulations of buprenorphine for pain management. It mentions the advantages of sublingual buprenorphine films, including easy dosage adjustment, abuse deterrent properties, generic availability, and convenience in administration. Insurance coverage challenges for sublingual buprenorphine are discussed, with recommendations for alternative formulations based on patient tolerance levels.<br /><br />The text also mentions the importance of proper dosing instructions for buprenorphine administration, highlighting its slow dissociation rate and sustained effect on opioid withdrawal suppression. It suggests specific protocols for dosing and administration to ensure optimal pain control and minimize side effects. Additionally, the document provides references to further resources and studies on buprenorphine for chronic pain management for additional information.
Keywords
buprenorphine
chronic pain management
opioid dependence
harm reduction
off-label use
overdose risk
respiratory depression
dosing options
sublingual buprenorphine films
insurance coverage challenges
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English